[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Papers Read Before the 13th Annual Meeting of the New England Society for Vascular Surgery Dixville Notch, NH, Sept 25 to Sept 26, 1986
August 1987

Markers of Thrombotic Activity in Arterial Disease

Author Affiliations

From the Departments of Surgery (Dr Donaldson and Ms Hadjimichael) and Hematology/Oncology (Ms Matthews and Dr Rickles), University of Connecticut School of Medicine, Farmington. Dr Donaldson is now with the Department of Surgery, Brigham and Women's Hospital, Boston.

Arch Surg. 1987;122(8):897-900. doi:10.1001/archsurg.1987.01400200047007

• Levels of the platelet degranulation product β-thromboglobulin (BTG) and the fibrinogen degradation product fibrinopeptide A (FPA) were measured in 26 asymptomatic subjects (group 1), 17 patients with peripheral vascular disease (PVD) (group 2), and 12 patients with PVD and bypass grafts (group 3). Mean BTG and FPA levels were elevated in both groups 2 and 3, indicating increased thrombotic activity in patients with PVD. Results of serial BTG and FPA assays in group 3 patients suggested a trend downward. These markers may be useful for estimating disease severity and prognosis, extent of graft healing and patency, and efficacy of therapeutic intervention.

(Arch Surg 1987;122:897-900)